Also, CD133 silencing has been directly correlated with epithelial-mesenchymal transition (EMT) inhibition in gastric cancer (downregulation of Snail, Slug, N-cadherin proteins) [76] and with suppressed invasion and metastasis in pancreatic cancer [77]. Here, PROM1 is linked to pancreatic neoplasm.